![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1240, 2009-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for ovarian cancer
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Association between antidepressants and breast/ovarian cancer
By Pae Chi-Un
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Strong growth predicted for ovarian cancer & IBS drug markets
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 602, 2010-01 ,pp. :